Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,deferredLongTermLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,priceHint,regularMarketChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,currency,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,shortName,exchangeDataDelayedBy,market,marketState,epsTrailingTwelveMonths,twoHundredDayAverageChangePercent,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,IZOZF,5006629.0,40783100,,,-2250694,,-2250694,567963,-269498,-2218132,-2218132,,,,,,0,0,2218132,269498,-32562,,-2250694,-2250694,124273.0,5006629.0,120813.0,5130902.0,9238166.0,255000.0,-5420010.0,1188473.0,120813.0,4606451.0,124273.0,1188473.0,2028.0,5008061.0,43721.0,124273.0,40229,-120813,1716934,-271385,1780371,1483861,-112260,411,988919,-63437,1380260,4883788.0,en-US,US,EQUITY,False,Delayed Quote,55985,0.06099999,0.11531189,0.529 - 1.31,-0.71999997,-0.5496183,0.529,1.31,0.123,0.57257146,0.017428517,0.030439027,0.7554348,-0.16543484,24313132,4,1.7241362,4.7967477,15,America/New_York,EDT,-14400000,0.58645 - 0.5953,0.58,finmb_552160888,Other OTC,Izotropic Corporation,CAD,44987,USD,False,False,0.59,1630522500,0.00999999,0.58645,0.5953,0.58645,14941,PNK,IZOTROPIC CORPORATION,0,us_market,PRE,-0.1,-0.21899287,2.74,,,1.31,0.529,0.5726,0.7554,44.99k,55.98k,40.78M,,35.17M,16.29%,0.00%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2020","Jan 30, 2021",0.00%,0.00%,-81.72%,-150.17%,,,,-63.85k,-3.53M,-3.68M,-0.1000,,4.61M,0.11,,,40.30,0.12,-2.35M,-1M,Value,V4A 2H9,Healthcare,"Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",Surrey,833 496 2677,BC,1609372800,Canada,http://izocorp.com,86400,800 â 15355 24th Avenue,Diagnostics & Research,Suite 424
t-1,IZOZF,4160129.0,40783100,,,-371319,,-371319,181356,-1176,-339768,-339768,,,,,,0,0,339768,1176,-31551,,-371319,-371319,84044.0,4160129.0,,4244173.0,6671062.0,,-3169316.0,658383.0,,3122590.0,84044.0,658383.0,2439.0,4241734.0,1032640.0,66526.0,19579,-120813,4069034,7038,4192885,2896135,-1172899,411,-985433,-123851,156825,4157690.0,en-US,US,EQUITY,False,Delayed Quote,55985,0.06099999,0.11531189,0.529 - 1.31,-0.71999997,-0.5496183,0.529,1.31,0.123,0.57257146,0.017428517,0.030439027,0.7554348,-0.16543484,24313132,4,1.7241362,4.7967477,15,America/New_York,EDT,-14400000,0.58645 - 0.5953,0.58,finmb_552160888,Other OTC,Izotropic Corporation,CAD,44987,USD,False,False,0.59,1630522500,0.00999999,0.58645,0.5953,0.58645,14941,PNK,IZOTROPIC CORPORATION,0,us_market,PRE,-0.1,-0.21899287,2.74,,,1.31,0.529,0.5726,0.7554,44.99k,55.98k,40.78M,,35.17M,16.29%,0.00%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2020","Jan 30, 2021",0.00%,0.00%,-81.72%,-150.17%,,,,-63.85k,-3.53M,-3.68M,-0.1000,,4.61M,0.11,,,40.30,0.12,-2.35M,-1M,Value,V4A 2H9,Healthcare,"Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",Surrey,833 496 2677,BC,1609372800,Canada,http://izocorp.com,86400,800 â 15355 24th Avenue,Diagnostics & Research,Suite 424
t-2,IZOZF,305589.0,40783100,,,-448818,,-448818,355978,-237,-403814,-403814,,,,,,0,0,403814,237,-45004,,-448818,-448818,64465.0,305589.0,,370054.0,2729503.0,,-2797997.0,374083.0,,226455.0,64465.0,374083.0,2850.0,367204.0,14245.0,55965.0,-5527,-120813,4069034,19629,4192885,-387117,-387117,411,-985433,-123851,47188,302739.0,en-US,US,EQUITY,False,Delayed Quote,55985,0.06099999,0.11531189,0.529 - 1.31,-0.71999997,-0.5496183,0.529,1.31,0.123,0.57257146,0.017428517,0.030439027,0.7554348,-0.16543484,24313132,4,1.7241362,4.7967477,15,America/New_York,EDT,-14400000,0.58645 - 0.5953,0.58,finmb_552160888,Other OTC,Izotropic Corporation,CAD,44987,USD,False,False,0.59,1630522500,0.00999999,0.58645,0.5953,0.58645,14941,PNK,IZOTROPIC CORPORATION,0,us_market,PRE,-0.1,-0.21899287,2.74,,,1.31,0.529,0.5726,0.7554,44.99k,55.98k,40.78M,,35.17M,16.29%,0.00%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2020","Jan 30, 2021",0.00%,0.00%,-81.72%,-150.17%,,,,-63.85k,-3.53M,-3.68M,-0.1000,,4.61M,0.11,,,40.30,0.12,-2.35M,-1M,Value,V4A 2H9,Healthcare,"Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",Surrey,833 496 2677,BC,1609372800,Canada,http://izocorp.com,86400,800 â 15355 24th Avenue,Diagnostics & Research,Suite 424
t-3,IZOZF,707219.0,40783100,,,-605140,,-605140,576174,-54436,-570858,-570858,,,,,,0,0,570858,54436,-34282,,-605140,-605140,69992.0,707219.0,,777211.0,2729503.0,,-2349179.0,326895.0,,613572.0,69992.0,326895.0,3261.0,773950.0,47207.0,61492.0,-313128,-120813,1230000,37954,1230000,553702,-676298,806,10050,-123851,193160,703958.0,en-US,US,EQUITY,False,Delayed Quote,55985,0.06099999,0.11531189,0.529 - 1.31,-0.71999997,-0.5496183,0.529,1.31,0.123,0.57257146,0.017428517,0.030439027,0.7554348,-0.16543484,24313132,4,1.7241362,4.7967477,15,America/New_York,EDT,-14400000,0.58645 - 0.5953,0.58,finmb_552160888,Other OTC,Izotropic Corporation,CAD,44987,USD,False,False,0.59,1630522500,0.00999999,0.58645,0.5953,0.58645,14941,PNK,IZOTROPIC CORPORATION,0,us_market,PRE,-0.1,-0.21899287,2.74,,,1.31,0.529,0.5726,0.7554,44.99k,55.98k,40.78M,,35.17M,16.29%,0.00%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2020","Jan 30, 2021",0.00%,0.00%,-81.72%,-150.17%,,,,-63.85k,-3.53M,-3.68M,-0.1000,,4.61M,0.11,,,40.30,0.12,-2.35M,-1M,Value,V4A 2H9,Healthcare,"Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.",Surrey,833 496 2677,BC,1609372800,Canada,http://izocorp.com,86400,800 â 15355 24th Avenue,Diagnostics & Research,Suite 424
